These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 9513036)
1. [Unclassified cardiomyopathies: subspecies and their transformation]. Ikeda Y; Kawai S; Okada R; Yamaguchi H J Cardiol; 1998 Feb; 31(2):91-7. PubMed ID: 9513036 [TBL] [Abstract][Full Text] [Related]
2. [Hypertrophic cardiomyopathy with left ventricular dilatation]. Iwami G; Miyazaki Y; Matsuyama K; Shida M; Ooga M; Furuta Y; Ikeda H; Toshima H; Chiba M; Koga Y J Cardiol; 1988 Jun; 18(2):319-28. PubMed ID: 3249261 [TBL] [Abstract][Full Text] [Related]
3. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure]. Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295 [TBL] [Abstract][Full Text] [Related]
4. Relation between myocardial histological changes and ventricular tachycardia in cardiomyopathy: a study by 24-hour ECG-monitoring and endomyocardial biopsy. Segawa I; Suzuki T; Kato M; Tashiro A; Satodate R Heart Vessels Suppl; 1990; 5():37-40. PubMed ID: 2093710 [TBL] [Abstract][Full Text] [Related]
5. [Reliability and limitation of various diagnostic methods including nuclear medicine in myocardial disease (author's transl)]. Tokuyasu Y; Kusakabe K; Yamazaki T; Tazaki E; Sekiguchi M; Hiroe M; Morimoto S; Fujioka T; Nakamura K; Hirosawa K J Cardiogr; 1981 Dec; 11(4):1113-25. PubMed ID: 7201492 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984 [TBL] [Abstract][Full Text] [Related]
8. Myocardial structure and left ventricular function in hypertrophic and dilative cardiomyopathy and aortic valve disease. Kunkel B; Schneider M Z Kardiol; 1987; 76 Suppl 3():9-13. PubMed ID: 3433878 [TBL] [Abstract][Full Text] [Related]
9. [Familial cardiomyopathy with different clinical features in individual members]. Kudo K; Yamada M; Imai H; Katagiri M; Ozawa S; Ida Y; Okada R J Cardiol; 1987 Dec; 17(4):907-14. PubMed ID: 3506615 [TBL] [Abstract][Full Text] [Related]
10. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes. Xu Q; Dewey S; Nguyen S; Gomes AV J Mol Cell Cardiol; 2010 May; 48(5):899-909. PubMed ID: 20298698 [TBL] [Abstract][Full Text] [Related]
11. [Characteristics of myocardial diseases in the elderly]. Sugishita Y; Iida K; Iwasaki Y; el Sersi M; Fujieda K Nihon Ronen Igakkai Zasshi; 1994 Mar; 31(3):205-9. PubMed ID: 8207870 [TBL] [Abstract][Full Text] [Related]
12. [Prognosis of hypertrophic cardiomyopathy: echocardiographic and postmortem histopathologic study of 30 patients]. Emoto R; Yokota Y; Miki T; Nomura H; Miki T; Usuki S; Chou HT; Kurozumi H; Seo T; Fukuzaki H J Cardiol; 1988 Sep; 18(3):695-703. PubMed ID: 3249285 [TBL] [Abstract][Full Text] [Related]
13. [Numbers and sizes of myocytes, amount of interstitial space, fibrosis and disarray in dilated cardiomyopathy]. Fujiwara H; Onodera T; Tanaka M; Fujiwara T; Kawai C; Hamashima Y J Cardiogr Suppl; 1986; (9):27-33. PubMed ID: 3760614 [TBL] [Abstract][Full Text] [Related]
14. [Malignant familial cardiomyopathy with sudden death, typical asymmetric septal hypertrophy and dilated cardiomyopathy-like features]. Seo T; Yokota Y; Maehashi N; Takarada A; Kubo M; Toh S; Nakanishi O; Masuda J; Fujitani K; Fukuzaki H J Cardiogr; 1986 Mar; 16(1):81-94. PubMed ID: 3782892 [TBL] [Abstract][Full Text] [Related]
15. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. Biagini E; Coccolo F; Ferlito M; Perugini E; Rocchi G; Bacchi-Reggiani L; Lofiego C; Boriani G; Prandstraller D; Picchio FM; Branzi A; Rapezzi C J Am Coll Cardiol; 2005 Oct; 46(8):1543-50. PubMed ID: 16226182 [TBL] [Abstract][Full Text] [Related]
16. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome. Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973 [TBL] [Abstract][Full Text] [Related]
17. Comparison of percentage area of myocardial fibrosis and disarray in patients with classical form and dilated phase of hypertrophic cardiomyopathy. Iida K; Yutani C; Imakita M; Ishibashi-Ueda H J Cardiol; 1998 Sep; 32(3):173-80. PubMed ID: 9783238 [TBL] [Abstract][Full Text] [Related]
18. [Two-dimensional echocardiographic recognition of dilated cardiomyopathy: comparison with postmortem studies]. Honma M; Sugawara M; Ikeda Y; Ataka Y; Sudo H; Ikeda S; Miura M; Kanazawa T; Shozawa T J Cardiogr; 1985 Dec; 15(4):1057-69. PubMed ID: 3841889 [TBL] [Abstract][Full Text] [Related]
19. Importance of endomyocardial biopsy in unexplained cardiomyopathy in China: a report of 53 consecutive patients. Tian Z; Zeng Y; Cheng KA; Gao P; Zhao DC; Cui QC; Jiang XC; Chen LF; Fang Q Chin Med J (Engl); 2010 Apr; 123(7):864-70. PubMed ID: 20497679 [TBL] [Abstract][Full Text] [Related]